10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates

10x Genomics (TXG) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of$ 0.47. This compares to loss of $0.53 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 31.91%. A quarter ago, it was expected that this life science technology company would post a loss of$ 0.46 per share when it actually produced a loss of $0.50, delivering a surprise of -8.70%. Over the last four quarters, th ...